Communications of the ACM
A Healthy Dose of AI
Building artificial intelligence into medical devices can speed diagnoses and potentially improve treatments and outcomes.
From ACM NewsAn edited collection of advanced computing news from Communications of the ACM, ACM TechNews, other ACM resources, and news sites around the Web.
From ACM News
Legal Confusion Threatens to Slow Data Science
Knowledge from millions of biological studies encoded into one network—that is Daniel Himmelstein's alluring description of Hetionet, a free online resource that...
From ACM News
'ransomware' Cyberattack Highlights Vulnerability of niversities
The first Patrick Feng knew about a cyberattack on his university was when one of his colleagues told him that her computer had been infected by hackers and rendered...
From ACM News
Plan to Synthesize Human Genome Elicits Mixed Response
Proposals for a large public-private initiative to synthesize an entire human genome from scratch—an effort that could take a decade and require billions of dollars...
From ACM News
Digital Forensics: From the Crime Lab to the Library
When archivists at California's Stanford University received the collected papers of the late palaeontologist Stephen Jay Gould in 2004, they knew right away they...
From ACM News
1,500 Scientists Lift the Lid on Reproducibility
More than 70% of researchers have tried and failed to reproduce another scientist's experiments, and more than half have failed to reproduce their own experiments...
From ACM News
Gene-Edited Crispr Mushroom Escapes S Regulation
The US Department of Agriculture (USDA) will not regulate a mushroom genetically modified with the gene-editing tool CRISPR–Cas9.
From ACM News
'minimal' Cell Raises Stakes in Race to Harness Synthetic Life
Genomics entrepreneur Craig Venter has created a synthetic cell that contains the smallest genome of any known, independent organism.
From ACM News
Living Factories of the Future
From an evolutionary perspective, yeast has no business producing a pain killer. But by re-engineering the microbe's genome, Christina Smolke at Stanford University...
From ACM News
Welcome to the Crispr Zoo
Timothy Doran's 11-year-old daughter is allergic to eggs. And like about 2% of children worldwide who share the condition, she is unable to receive many routine...
From ACM News
Crispr: Gene Editing Is Just the Beginning
Whenever a paper about CRISPR–Cas9 hits the press, the staff at Addgene quickly find out.
From ACM News
Should You Edit Your Children's Genes?
Ruthie Weiss's basketball team seemed to be minutes away from its fourth straight loss.
From ACM News
Dna Tags Help the Hunt For Drugs
Nestled in a plastic box, in an ordinary laboratory freezer on the second floor of a concrete building in Waltham, Massachusetts, is a clear test tube that contains...
From ACM News
k Scientists Gain Licence to Edit Genes in Human Embryos
Scientists in London have been granted permission to edit the genomes of human embryos for research, UK fertility regulators announced. The 1 February approval...
From ACM News
Bitter Fight Over Crispr Patent Heats Up
A versatile technique for editing genomes has been called the biggest biotechnology advancesince the polymerase chain reaction (PCR), and the US Patent and Trademark...
From ACM News
Gene-Editing Summit Supports Some Research in Human Embryos
Gene-editing technology should not be used to modify human embryos that are intended for use in establishing a pregnancy, an international summit declared in a...
From ACM News
Biologists Create More Precise Molecular Scissors For Genome Editing
By tweaking an enzyme that cuts DNA, synthetic biologists say that they can make genome editing even more specific—an essential improvement if the technique is...
From ACM News
Genome Editing: 7 Facts About a Revolutionary Technology
The ethics of human-genome editing is in the spotlight again as a large international meeting on the topic is poised to kick off in Washington DC.
From ACM News
Leap-Second Decision Delayed By Eight Years
A leap second is gone in the blink of an eye. But a long-awaited decision on whether to ditch these occasional time insertions—which ensure that official time is...
From ACM Careers
Synthetic Biology Lures Silicon Valley Investors
In 2012, Emily Leproust was trying to raise money to start Twist Bioscience, a company that aimed to synthesize DNA more quickly and more cheaply than existing...
From ACM News